KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict response to anti-VEGF therapy in diabetic macular edema.
Luvisi and colleagues used a convolutional neural network to find out if they could predict which treatment-naive patients would not respond to anti-VEGF therapy after their first treatment. The AI model predicted 55 out of 57 patients who responded and eight out of 16 patients who did not respond.
“It proved a useful tool in trying to find patients that are going to respond to anti-VEGF on their initial